Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6β-hydroxycortisol

This publication has 14 references indexed in Scilit:

• The pharmacokinetics of ethynylestradiol in the presence and absence of gestodene and desogestrel
  Contraception, 1991
• Group comparison of serum ethinyl estradiol, SHBG and CBG levels in 83 women using two low-dose combination oral contraceptives for three months
  Contraception, 1991
• Concentration of Ethinyl Estradiol in the Serum of 31 Young Women following a Treatment Period of 3 Months with Two Low-Dose Oral Contraceptives in an Intraindividual Cross-Over Design
  Hormone Research, 1991
• Inhibition of oral contraceptive steroid—metabolizing enzymes by steroids and drugs
  American Journal of Obstetrics and Gynecology, 1990
• Comparison of Serum Ethinyl Estradiol, Sex-Hormone-Binding Globulin, Corticoid-Binding Globulin and Cortisol Levels in Women Using Two Low-Dose Combined Oral Contraceptives
  Hormone Research, 1990
• Relative Bioavailability of Ethinyl Estradiol from Two Different Oral Contraceptive Formulations after Single Oral Administration to 18 Women in an Intraindividual Cross-Over Design
  Hormone Research, 1990
• Interaction with the pharmacokinetics of ethinylestradiol and progestogens contained in oral contraceptives
  Contraception, 1989
• ELISA of 6-beta-hydroxycortisol in human urine: Diurnal variations and effects of antiepileptic therapy
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1986
• HUMAN CORTICOSTEROID BINDING GLOBULIN
  Clinical Endocrinology, 1981
• Investigations of pharmacokinetics of ethinyloestradiol to specific consideration of a possible first-pass effect in women
  Contraception, 1979